Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 693,650 | 895,180 | 572,900 | 512,580 | 424,000 |
| Marketable Securities | 165,070 | 99,640 | 0 | 720 | 0 |
| Receivables | 103,130 | 86,850 | 102,560 | 101,100 | 98,850 |
| Inventories | 79,920 | 80,590 | 86,730 | 88,370 | 86,520 |
| Other current assets | 45,000 | 42,200 | 52,970 | 38,260 | 44,310 |
| TOTAL | $1,086,770 | $1,204,460 | $815,160 | $741,030 | $653,680 |
| Non-Current Assets | |||||
| Investments And Advances | 239,490 | 93,900 | 0 | 0 | 0 |
| Other Non-Current Assets | 1,212,470 | 1,243,040 | 1,295,390 | 1,385,630 | 1,465,400 |
| TOTAL | $1,451,960 | $1,336,940 | $1,295,390 | $1,385,630 | $1,465,400 |
| Total Assets | $2,674,300 | $2,667,210 | $2,225,900 | $2,258,570 | $2,292,630 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 290 | 290 | 300 | 490 | 840 |
| Accounts payable and accrued liabilities | 26,130 | 20,640 | 22,130 | 25,060 | 26,740 |
| Accrued Expenses | 77,100 | 76,600 | 81,640 | 68,960 | 61,860 |
| TOTAL | $138,140 | $126,580 | $143,130 | $129,600 | $120,590 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,620 | 3,530 | 14,310 | 17,800 | 0 |
| Other Non-Current Liabilities | 691,320 | 691,020 | 187,780 | 187,720 | 209,110 |
| TOTAL | $853,750 | $869,530 | $379,540 | $404,550 | $430,170 |
| Total Liabilities | $991,920 | $996,130 | $522,690 | $534,170 | $550,770 |
| Shareholders' Equity | |||||
| Common Shares | 530 | 530 | 520 | 520 | 520 |
| Retained earnings | -177,770 | -192,290 | -156,700 | -119,280 | -84,190 |
| Other shareholders' equity | -8,890 | -7,270 | 1,910 | -4,780 | -4,240 |
| TOTAL | $1,682,380 | $1,671,070 | $1,703,200 | $1,724,390 | $1,741,860 |
| Total Liabilities And Equity | $2,674,300 | $2,667,200 | $2,225,890 | $2,258,560 | $2,292,630 |